SEC Form 4 · accession 0001127602-17-031184
Bioverativ Inc. · BIVV
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Andrea DiFabio
Officer — EVP, Chief Legal Officer
Period of report
Nov 2, 2017
Accepted (ET)
Nov 3, 2017 · 4:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001681689
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1,F2 | Nov 2, 2017 | F | 636 | $53.65 | D | 30,731 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents the number of shares forfeited by the reporting person to cover the payment of taxes incurred as a result of vesting of restricted stock units.
- F2Includes an aggregate of 548.5575 shares acquired under the Company's Employee Stock Purchase Plan on April 5, 2017, July 6, 2017 and September 29, 2017.